News|Videos|January 9, 2024
Orbis CEO and president gives insight into 2024 plans
Author(s)David Hutton
David Hutton of Ophthalmology Times talks with Derek Hodkey, CEO and president of Orbis International, about 2023 in review as well as plans for the company moving into 2024.
Advertisement
David Hutton of Ophthalmology Times talks with Derek Hodkey, CEO and president of Orbis International, about 2023 in review as well as plans for the company moving into 2024.
Video Transcript
Editor's note - This transcript has been edited for clarity.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Moorfields study reveals sharp rise in glaucoma burden across the UK
2
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan
3
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
4
Why individualized glaucoma care remains essential amid uneven patient awareness
5










































